Rheumatology Research

Get the Flash Player to see this player.

At a time when many pediatric hospitals are unable to offer even a single full-time pediatric rheumatologist, the Division of Pediatric Rheumatology at Children’s Hospital of Pittsburgh of UPMC has established one of the largest and most comprehensive pediatric rheumatology programs in the United States. Leading physicians in pediatric rheumatology have committed themselves to finding the causes and cures for pediatric rheumatic diseases.

Researchers are focusing on understanding the inflammatory response in arthritis which will improve the safety and effectiveness of new protein-based drugs that show promise in relieving joint inflammation among children with juvenile rheumatoid arthritis and other chronic rheumatic diseases, such as lupus, dermatomyositis, and joint and muscle pain.

Children’s rheumatology scientists work closely with the pharmaceutical industry and with the Childhood Arthritis and Rheumatology Research Network to test and validate novel therapeutic approaches for children with rheumatic diseases. The laboratory has received funding from both the Arthritis foundation, and the National Institutes of Health (NIH), including an NIH training grant to train the next generation of pediatric rheumatologists.

As one of the foremost programs devoted to children with rheumatic diseases in the United States, Children’s Rheumatology Research Laboratory has emerged as a leader in autoimmunity research and the study of innovative therapies for arthritis.

Clinical Team

Chief of Service
Raphael Hirsch, MD

Our Researchers
Abbe N. de Vallejo, PhD
Daniel A. Kietz, MD
Paul Rosen, MD, MPH, MMM
Margalit E. Rosenkranz, MD
Kathryn Torok, MD